MAPT and Alzheimer disease: Our findings are also responsive to the update to the amyloid-tau-neurodegeneration (ATN) research framework (18), as we demonstrate MTD’s association with core AD biomarkers including amyloid and tau PET, HV – a non-specific neurodegeneration biomarker, and WMH indicating common non-AD vascular co-pathology.